MRNA - Moderna, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 55.87B
Enterprise Value 34.79B
Trailing P/E N/A
Forward P/E 1-9.72
PEG Ratio (5 yr expected) 1-0.69
Price/Sales (ttm)55.23
Price/Book (mrq)4.38
Enterprise Value/Revenue 345.11
Enterprise Value/EBITDA 6-9.67

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 32.56%
52 Week High 329.79
52 Week Low 311.54
50-Day Moving Average 314.55
200-Day Moving Average 318.47

Share Statistics

Avg Vol (3 month) 31.81M
Avg Vol (10 day) 34.32M
Shares Outstanding 5330.18M
Float 188.66M
% Held by Insiders 126.31%
% Held by Institutions 140.84%
Shares Short (Aug 15, 2019) 412.08M
Short Ratio (Aug 15, 2019) 410.14
Short % of Float (Aug 15, 2019) 45.27%
Short % of Shares Outstanding (Aug 15, 2019) 43.66%
Shares Short (prior month Jul 15, 2019) 410.32M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-493.59%

Management Effectiveness

Return on Assets (ttm)-19.95%
Return on Equity (ttm)-39.36%

Income Statement

Revenue (ttm)106.29M
Revenue Per Share (ttm)0.50
Quarterly Revenue Growth (yoy)-54.70%
Gross Profit (ttm)-319.01M
EBITDA -495.97M
Net Income Avi to Common (ttm)-499.63M
Diluted EPS (ttm)-2.35
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.07B
Total Cash Per Share (mrq)3.24
Total Debt (mrq)33.59M
Total Debt/Equity (mrq)2.51
Current Ratio (mrq)6.78
Book Value Per Share (mrq)4.06

Cash Flow Statement

Operating Cash Flow (ttm)-427.38M
Levered Free Cash Flow (ttm)-291.67M